Physician profile
Paul Robert Andre
NPI 1710220611
$1,893.60
in general payments reported to CMS, 2019-2025
13 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $190 · 2020: $354 · 2021: $177 · 2022: $229 · 2023: $325 · 2024: $463 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $943.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $943.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $553.53 | 2019-2024 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $300.91 | 2020-2023 | Camzyos |
| Pfizer INC. | $217.07 | 2023-2024 | |
| Amgen INC. | $181.04 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $161.47 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $149.34 | 2022-2024 | Xarelto |
| Cvrx, INC. | $105.77 | 2023 | Barostim Neo System |
| Medtronic Vascular, INC. | $88.17 | 2019 | |
| Irhythm Technologies, INC. | $43.97 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Abiomed | $40.00 | 2021 | |
| Lantheus Medical Imaging, INC. | $19.91 | 2019 | |
| Ge Healthcare | $19.04 | 2025 | |
| Chiesi USA, INC. | $13.38 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Andre listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.